{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05938699",
            "orgStudyIdInfo": {
                "id": "NCX 470-05"
            },
            "organization": {
                "fullName": "Nicox Ophthalmics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution",
            "officialTitle": "Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution - A Double-Masked, Placebo-Controlled, Phase 3b Clinical Trial (Whistler)",
            "acronym": "Whistler",
            "therapeuticArea": [
                "Ophthalmology"
            ],
            "study": "aqueous-humor-dynamics-of-ncx-ophthalmic-solution"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-01",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-12-12",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-03-31",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2025-03-31",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-06-15",
            "studyFirstSubmitQcDate": "2023-07-06",
            "studyFirstPostDateStruct": {
                "date": "2023-07-10",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-01-09",
            "lastUpdatePostDateStruct": {
                "date": "2024-01-11",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Nicox Ophthalmics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This is a double-masked, placebo-controlled study which will determine the action of NCX 470 ophthalmic solution, 0.1% on aqueous humor dynamic parameters in healthy volunteers or subjects with OHT."
        },
        "conditionsModule": {
            "conditions": [
                "Open Angle Glaucoma"
            ],
            "keywords": [
                "glaucoma",
                "NCX 470",
                "nitric oxide",
                "prostaglandin analogue"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2",
                "PHASE3"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "BASIC_SCIENCE",
                "maskingInfo": {
                    "masking": "TRIPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 20,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "NCX 470 0.1%",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "NCX 470 0.1% - one drop in the randomized eye once a day for 8 days",
                    "interventionNames": [
                        "Drug: NCX 470"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Artificial tears - one drop in the randomized eye once a day for 8 days",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "NCX 470",
                    "description": "NCX 470 0.1% vs Placebo",
                    "armGroupLabels": [
                        "NCX 470 0.1%"
                    ],
                    "otherNames": [
                        "nitric oxide (NO)-donating bimatoprost prostaglandin analog"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "NCX 0.1% vs Placebo",
                    "armGroupLabels": [
                        "Placebo"
                    ],
                    "otherNames": [
                        "Artificial tears"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Change in AHD",
                    "description": "The primary efficacy endpoint is change from baseline in aqueous humor dynamics AHD). AHD is calculated by using well establish techniques which include capturing the following:\n\nAqueous humor flow rates from fluorescein clearance; Outflow facility using constant weigh tonography; Episcleral venous pressure using a venomanometer.\n\nThe change in ADH will be calculate in normals following 8 (\u00b11) days of dosing of NCX 470 0.1% compared to placebo.",
                    "timeFrame": "8 days"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. \u226518 years of age\n2. Either gender\n3. Subjects without glaucoma\n4. Qualifying IOP at Screening Visit\n\nExclusion Criteria:\n\n1. Narrow anterior chamber angles or disqualifying central corneal thickness in either eye\n2. Clinically significant ocular disease in either eye\n3. Uncontrolled systemic disease\n4. Serious hypersensitivity to topical anesthetic eye drops\n5. Subjects with a known hypersensitivity or contraindications to any of the ingredients in the study medications",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Siobhan Garbutt, PhD",
                    "role": "CONTACT",
                    "phone": "984-710-5354",
                    "email": "NCX470@nicox.com"
                }
            ],
            "locations": [
                {
                    "facility": "Mayo Clinic",
                    "status": "RECRUITING",
                    "city": "Rochester",
                    "state": "Minnesota",
                    "zip": "55905",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Arthur Sit, MD",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.02163,
                        "lon": -92.4699
                    }
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000005901",
                    "term": "Glaucoma"
                },
                {
                    "id": "D000005902",
                    "term": "Glaucoma, Open-Angle"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009798",
                    "term": "Ocular Hypertension"
                },
                {
                    "id": "D000005128",
                    "term": "Eye Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9013",
                    "name": "Glaucoma",
                    "asFound": "Glaucoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9014",
                    "name": "Glaucoma, Open-Angle",
                    "asFound": "Open Angle Glaucoma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10024",
                    "name": "Hypertension",
                    "relevance": "LOW"
                },
                {
                    "id": "M12731",
                    "name": "Ocular Hypertension",
                    "relevance": "LOW"
                },
                {
                    "id": "M8271",
                    "name": "Eye Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC11",
                    "name": "Eye Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000069580",
                    "term": "Bimatoprost"
                },
                {
                    "id": "D000009569",
                    "term": "Nitric Oxide"
                },
                {
                    "id": "D000065346",
                    "term": "Lubricant Eye Drops"
                }
            ],
            "ancestors": [
                {
                    "id": "D000001993",
                    "term": "Bronchodilator Agents"
                },
                {
                    "id": "D000001337",
                    "term": "Autonomic Agents"
                },
                {
                    "id": "D000018373",
                    "term": "Peripheral Nervous System Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018927",
                    "term": "Anti-Asthmatic Agents"
                },
                {
                    "id": "D000019141",
                    "term": "Respiratory System Agents"
                },
                {
                    "id": "D000016166",
                    "term": "Free Radical Scavengers"
                },
                {
                    "id": "D000000975",
                    "term": "Antioxidants"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000018377",
                    "term": "Neurotransmitter Agents"
                },
                {
                    "id": "D000045462",
                    "term": "Endothelium-Dependent Relaxing Factors"
                },
                {
                    "id": "D000014665",
                    "term": "Vasodilator Agents"
                },
                {
                    "id": "D000064426",
                    "term": "Gasotransmitters"
                },
                {
                    "id": "D000020011",
                    "term": "Protective Agents"
                },
                {
                    "id": "D000000959",
                    "term": "Antihypertensive Agents"
                },
                {
                    "id": "D000009883",
                    "term": "Ophthalmic Solutions"
                },
                {
                    "id": "D000019999",
                    "term": "Pharmaceutical Solutions"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M21860",
                    "name": "Pharmaceutical Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M12814",
                    "name": "Ophthalmic Solutions",
                    "relevance": "LOW"
                },
                {
                    "id": "M30506",
                    "name": "Lubricant Eye Drops",
                    "asFound": "Unrelated",
                    "relevance": "HIGH"
                },
                {
                    "id": "M473",
                    "name": "Bimatoprost",
                    "asFound": "Resolution",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12507",
                    "name": "Nitric Oxide",
                    "asFound": "Vivo",
                    "relevance": "HIGH"
                },
                {
                    "id": "M5269",
                    "name": "Bronchodilator Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20963",
                    "name": "Anti-Asthmatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M21137",
                    "name": "Respiratory System Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4292",
                    "name": "Antioxidants",
                    "relevance": "LOW"
                },
                {
                    "id": "M20504",
                    "name": "Neurotransmitter Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M25496",
                    "name": "Endothelium-Dependent Relaxing Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M17412",
                    "name": "Vasodilator Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M21869",
                    "name": "Protective Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M4277",
                    "name": "Antihypertensive Agents",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "PhSol",
                    "name": "Pharmaceutical Solutions"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "AnAg",
                    "name": "Antihypertensive Agents"
                },
                {
                    "abbrev": "VaDiAg",
                    "name": "Vasodilator Agents"
                },
                {
                    "abbrev": "Resp",
                    "name": "Respiratory System Agents"
                }
            ]
        }
    },
    "hasResults": false
}